These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 15355668

  • 1. [A multi-center clinical trial of recombinant human thrombopoietin in chronic refractory idiopathic thrombocytopenic purpura].
    Zhao YQ, Wang QY, Zhai M, Xu J, Chen XQ, Liu WL, Zhang M, Song SJ, Wang JM, Meng FY, Shan YD.
    Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):608-10. PubMed ID: 15355668
    [Abstract] [Full Text] [Related]

  • 2. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM, Xu GX, Zhao YQ, Han SM, Shan YD.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [Abstract] [Full Text] [Related]

  • 3. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM, Zou XY, Zhao YQ, Han SM, Shan YD, Thrombopoietin Clinical Trail Cooperation Group.
    Zhonghua Yi Xue Za Zhi; 2004 Mar 02; 84(5):397-400. PubMed ID: 15061993
    [Abstract] [Full Text] [Related]

  • 4. [Clinical analysis of recombinant humanized thrombopoietin for treating 25 children with severe immune thrombocytopenia].
    Zheng J, Ma JY, Su Y, Yang J, Zhang RD, Zhou X, Wu RH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr 02; 22(2):393-8. PubMed ID: 24763011
    [Abstract] [Full Text] [Related]

  • 5. [Clinical tolerance test of recombinant human thrombopoietin].
    Zhao Y, Jiang J, Jiao L.
    Zhonghua Yi Xue Za Zhi; 2001 Dec 25; 81(24):1508-11. PubMed ID: 16200777
    [Abstract] [Full Text] [Related]

  • 6. [A clinical comparative study on treatment of severe newly diagnosed immune thrombocytopenia by recombinant human thrombopoietin combined with glucocorticoid].
    Gu SY, Zhuang JL, Zou SH, Li F, Wang ZM, Cheng YF, Wang WG, Cheng ZX, Yuan L, Cheng LY, Wei Z.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Oct 25; 34(10):883-6. PubMed ID: 24171964
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study.
    Liu X, Bai Y, Wang T, Song Y, Sun F, Xia R, Zhu F, Ma J, Lu Q, Ye X, Zhan X, Li L, Guo X, Cheng S, Li Y, Guo Z, Chen Y, Qian S, Qin L, Zhang Q, Cao S, Yang R.
    Platelets; 2023 Dec 25; 34(1):2157806. PubMed ID: 36597010
    [Abstract] [Full Text] [Related]

  • 8. [Clinical Analysis of Recombinant Human Thrombopoietin for Treatment of 46 Adult Patients with Newly Diagnosed Primary Immune Thrombocytopenia].
    Wang M, Liu YF, Sun H, Xie XS, Ma J, Gan SL, Dong YJ, Ren HY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr 25; 24(2):531-5. PubMed ID: 27151024
    [Abstract] [Full Text] [Related]

  • 9. Multiple cycles of recombinant human thrombopoietin therapy in a patient with chronic refractory idiopathic thrombocytopenic purpura.
    Hua B, Zou N, Wang S, Zhu T, Zhao Y.
    Blood Coagul Fibrinolysis; 2005 Jun 25; 16(4):291-5. PubMed ID: 15870550
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia.
    Wang X, Bi H, Liu L, Liu Y, Yin L, Yao J, Yu J, Tao W, Wei Y, Li Y, Yin L, Mu H, Du Y, Zhou Z.
    Platelets; 2023 Dec 25; 34(1):2271568. PubMed ID: 37941414
    [Abstract] [Full Text] [Related]

  • 11. [A clinical analysis of treatment with recombinant human thrombopoietin combined with large doses of dexamethasone in primary immune thrombocytopenia].
    Sun M, Wang X, Jiang M, Bao X, Wang L, Liu Y, Wang X, Guo X.
    Zhonghua Nei Ke Za Zhi; 2016 Mar 25; 55(3):202-5. PubMed ID: 26926372
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy and safety of recombinant human thrombopoietin in adult patients with primary immune thrombocytopenia during the perioperative period].
    Sun HP, Hu Q, You JH, Chen QS, Wang J, Li JM, Zhao WL.
    Zhonghua Xue Ye Xue Za Zhi; 2019 Mar 14; 40(3):191-194. PubMed ID: 30929384
    [Abstract] [Full Text] [Related]

  • 13. A multicentre double-blind, double-dummy, randomised study of recombinant human thrombopoietin versus eltrombopag in the treatment of immune thrombocytopenia in Chinese adult patients.
    Mei H, Xu M, Yuan G, Zhu F, Guo J, Huang R, Qin J, Lv T, Qin F, Cai H, Yin P, Qin T, Hu Y.
    Br J Haematol; 2021 Dec 14; 195(5):781-789. PubMed ID: 34528239
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH, Chen ZW, Ye XY, Lu S.
    Zhonghua Zhong Liu Za Zhi; 2008 Sep 14; 30(9):716-9. PubMed ID: 19173920
    [Abstract] [Full Text] [Related]

  • 15. [Value of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Dai XF, Yu J, Liu L, Wu G.
    Zhonghua Zhong Liu Za Zhi; 2008 Aug 14; 30(8):623-5. PubMed ID: 19102944
    [Abstract] [Full Text] [Related]

  • 16. Effect of recombinant human thrombopoietin on IL-2, IL-4 and platelet parameters in thrombocytopenic purpura.
    Zhao M, Liang X, Chen C, Du X, Dang X.
    Cell Mol Biol (Noisy-le-grand); 2023 May 31; 69(5):119-125. PubMed ID: 37571891
    [Abstract] [Full Text] [Related]

  • 17. A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy.
    Kong Z, Qin P, Xiao S, Zhou H, Li H, Yang R, Liu X, Luo J, Li Z, Ji G, Cui Z, Bai Y, Wu Y, Shao L, Peng J, Ma J, Hou M.
    Blood; 2017 Aug 31; 130(9):1097-1103. PubMed ID: 28630121
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
    Wolff SN, Herzig R, Lynch J, Ericson SG, Greer JP, Stein R, Goodman S, Benyunes MC, Ashby M, Jones DV, Fay J.
    Bone Marrow Transplant; 2001 Feb 31; 27(3):261-8. PubMed ID: 11277173
    [Abstract] [Full Text] [Related]

  • 19. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS, Mokhtar GM, El-Laboudy MA, Khalifa AS.
    Acta Haematol; 2006 Feb 31; 115(1-2):46-52. PubMed ID: 16424649
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A, Kovaleva L, Loria S, Alberca I, Hernandez F, Sandoval V, Sierra J, Vidaller A, Ayguasanosa J, Carretero M.
    Transfus Med; 2009 Oct 31; 19(5):260-8. PubMed ID: 19747289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.